Heartflow, Inc. (NASDAQ:HTFL – Get Free Report)’s share price crossed below its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $51.91 and traded as low as $48.27. Heartflow shares last traded at $48.46, with a volume of 3,705,135 shares.
Key Stories Impacting Heartflow
Investors following HTFL have been watching these stories:
- Positive Sentiment: Heartflow raised its 2026 revenue guidance to $262 million–$264 million, above the approximately $248.5 million consensus, signaling stronger expected growth. Financial results and guidance
- Positive Sentiment: Wells Fargo, Canaccord Genuity, Stifel and Baird raised their price targets to $68–$70 and maintained positive ratings, reflecting improved analyst expectations. Wells Fargo rating Canaccord Genuity rating Stifel rating Baird rating
- Negative Sentiment: A report said Heartflow’s CEO sold about $2.17 million worth of stock. Insider selling can concern investors, though the report alone does not establish the reason for the sale. CEO stock sale
Analyst Upgrades and Downgrades
Several research firms have weighed in on HTFL. Robert W. Baird raised their price target on Heartflow from $56.00 to $68.00 and gave the company an “outperform” rating in a report on Friday. Canaccord Genuity Group lifted their price target on Heartflow from $56.00 to $69.00 and gave the company a “buy” rating in a research report on Friday. Piper Sandler reissued an “overweight” rating and set a $64.00 price objective (up from $45.00) on shares of Heartflow in a report on Tuesday, October 20th. UBS Group assumed coverage on shares of Heartflow in a research report on Wednesday, September 9th. They issued a “neutral” rating and a $55.00 price objective on the stock. Finally, Benchmark reaffirmed a “buy” rating on shares of Heartflow in a research note on Friday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $60.12.
Heartflow Stock Performance
The stock has a 50-day simple moving average of $51.91 and a two-hundred day simple moving average of $35.23.
Heartflow (NASDAQ:HTFL – Get Free Report) last issued its quarterly earnings results on Thursday, November 12th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.18) by $0.15. Heartflow had a negative return on equity of 20.53% and a negative net margin of 33.11%. The firm had revenue of $72.86 million during the quarter. During the same period last year, the firm earned ($0.27) EPS. As a group, equities research analysts forecast that Heartflow, Inc. will post -0.75 EPS for the current fiscal year.
Insider Activity at Heartflow
In related news, CFO Vikram Verghese sold 29,714 shares of the business’s stock in a transaction that occurred on Friday, September 11th. The stock was sold at an average price of $50.06, for a total value of $1,487,482.84. Following the completion of the sale, the chief financial officer owned 184,789 shares in the company, valued at $9,250,537.34. The trade was a 13.85% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John Farquhar sold 38,900 shares of the company’s stock in a transaction that occurred on Monday, October 12th. The stock was sold at an average price of $49.57, for a total value of $1,928,273.00. Following the completion of the sale, the chief executive officer directly owned 283,014 shares of the company’s stock, valued at approximately $14,029,003.98. This represents a 12.08% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 332,403 shares of company stock valued at $16,602,786. Corporate insiders own 7.70% of the company’s stock.
Hedge Funds Weigh In On Heartflow
Several institutional investors and hedge funds have recently made changes to their positions in HTFL. XXEC Inc. bought a new stake in Heartflow in the second quarter worth $2,524,764,000. Quantinno Capital Management LP purchased a new stake in Heartflow during the first quarter valued at about $1,734,000. Sei Investments Co. grew its stake in shares of Heartflow by 342.5% during the first quarter. Sei Investments Co. now owns 67,048 shares of the company’s stock valued at $1,631,000 after buying an additional 51,895 shares during the last quarter. Bank of New York Mellon Corp bought a new position in shares of Heartflow during the second quarter valued at about $19,096,000. Finally, Handelsbanken Fonder AB purchased a new position in shares of Heartflow in the second quarter worth about $910,000.
Heartflow Company Profile
HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning. The company’s offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.
Further Reading
- Five stocks we like better than Heartflow
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Heartflow Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heartflow and related companies with MarketBeat.com's FREE daily email newsletter.
